2.1 Study design In this prospective, double-blind, cross-over interventional study, patients were randomized in balanced blocks (1:1) into two groups: Sequence 1, HA-first, received the control product (containing only hyaluronic acid 0.2%) for 4 weeks, followed by a 1-week washout, and then the experimental product (hyaluronic acid 0.2% + butyroyl glutathione 0.4%) for 4 weeks
CJC-1295 CJC-1295 is also a GHRH analog, but it is engineered to have a significantly longer half-life, lasting several days in the body
18,19 Given the confounding information, there is no established DR screening protocol upon GLP-1RA initiation
doi:10.1210/en.2018-00004 83
10.1093/bioinformatics/btp033 70 WoeseC
This is not a complete list of all common or serious side effects